Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison.
Sign Up to like & getrecommendations! Published in 2021 at "Current medical research and opinion"
DOI: 10.1080/03007995.2021.1971182
Abstract: OBJECTIVE In the absence of a head-to-head study, we assessed the comparative effectiveness of pegcetacoplan, a targeted C3 complement inhibitor, vs. ravulizumab, a C5 complement inhibitor, among patients with paroxysmal nocturnal hemoglobinuria (PNH) previously treated… read more here.
Keywords: treated eculizumab; ravulizumab; pegcetacoplan; comparative effectiveness ... See more keywords